Allogene Therapeutics

South San Francisco, United States

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Apr 2026

Post-IPO Equity

Biotechnology Health Diagnostics Oncology Pharmaceutical

Top Investors

Franklin TempletonTPGPfizerGilead SciencesPerceptive Advisors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Allogene Therapeutics

Who are Allogene Therapeutics's investors?

Allogene Therapeutics's investors include Franklin Templeton, TPG, Pfizer, Gilead Sciences, Perceptive Advisors.

Where is Allogene Therapeutics headquartered?

Allogene Therapeutics is headquartered in South San Francisco, United States.

What does Allogene Therapeutics do?

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

What stage is Allogene Therapeutics at?

Allogene Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 14, 2026.

MLA

"Allogene Therapeutics — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/allogene-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Allogene Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/allogene-therapeutics

Wikipedia (cite web)

{{cite web |title=Allogene Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/allogene-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 14, 2026.